Cargando…
Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence
Multiple pathological mechanisms are involved in the development of chemotherapy-induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the molecular mechanisms underlying chemotherapy-induced axonal degeneration. This review integrates evidence from preclinical and clinical...
Autores principales: | Park, Susanna B, Cetinkaya-Fisgin, Aysel, Argyriou, Andreas A, Höke, Ahmet, Cavaletti, Guido, Alberti, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579520/ https://www.ncbi.nlm.nih.gov/pubmed/37015772 http://dx.doi.org/10.1136/jnnp-2021-328323 |
Ejemplares similares
-
Cisplatin induced neurotoxicity is mediated by Sarm1 and calpain activation
por: Cetinkaya-Fisgin, Aysel, et al.
Publicado: (2020) -
Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
por: Cavaletti, Guido, et al.
Publicado: (2021) -
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity
por: Alberti, Paola, et al.
Publicado: (2021) -
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity
por: Zhu, Jing, et al.
Publicado: (2016) -
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders
por: Juenger, Valentin, et al.
Publicado: (2020)